Northwest Biotherapeutics reported 12.28M in Operating Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Agenus AGEN:US $ 61.4M 12.89M
Applied Genetic Technologies AGTC:US $ 13.58M 4.86M
AstraZeneca AZN:LN 10.51B 1.79B
Bristol Myers Squibb BMY:US $ 9.1B 247M
Celldex Therapeutics CLDX:US $ 23.43M 2.76M
Cti Biopharma CTIC:US $ 37.39M 2.02M
Cytori Therapeutics CYTX:US $ 3.93M 13K
Cytrx CYTR:US 1.29M 7.73M
Eisai 4523:JP Y 211704M 22380M
Genocea Biosciences GNCA:US $ 16.04M 2.63M
Infinity Pharmaceuticals INFI:US $ 13.06M 1.11M
Merk MRK:US $ 10332M 386M
Mirati Therapeutics MRTX:US $ 184.93M 12.45M
Northwest Biotherapeutics NWBO:US 12.28M 1.58M
Pfizer PFE:US $ 15788M 3271M